Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Biol Chem ; 276(12): 8746-52, 2001 Mar 23.
Article in English | MEDLINE | ID: mdl-11121428

ABSTRACT

CD98 is a cell surface heterodimer formed by the covalent linkage of CD98 heavy chain (CD98hc) with several different light chains to form amino acid transporters. CD98hc also binds specifically to the integrin beta(1A) cytoplasmic domain and regulates integrin function. In this study, we examined the relationship between the ability of CD98hc to stimulate amino acid transport and to affect integrin function. By constructing chimeras with CD98hc and a type II transmembrane protein (CD69), we found that the cytoplasmic and transmembrane domains of CD98hc are required for its effects on integrin function, while the extracellular domain is required for stimulation of isoleucine transport. Consequently, the capacity to promote amino acid transport is not required for CD98hc's effect on integrin function. Furthermore, a mutant of CD98hc that lacks its integrin binding site can still promote increased isoleucine transport. Thus, these two functions of CD98hc are separable and require distinct domains of the protein.


Subject(s)
Amino Acids/metabolism , Antigens, CD/physiology , Carrier Proteins/physiology , Integrins/metabolism , Animals , Antigens, CD/chemistry , Biological Transport , Carrier Proteins/chemistry , Cell Line , Cricetinae , Fusion Regulatory Protein-1 , Structure-Activity Relationship
2.
J Biol Chem ; 275(7): 5059-64, 2000 Feb 18.
Article in English | MEDLINE | ID: mdl-10671548

ABSTRACT

CD98 is a type II transmembrane protein involved in neutral and basic amino acid transport and in cell fusion events. CD98 was implicated in the function of integrin adhesion receptors by its capacity to reverse suppression of integrin activation by isolated integrin beta(1A) domains. Here we report that CD98 associates with integrin beta cytoplasmic domains with a unique integrin class and splice variant specificity. In particular, CD98 interacted with the ubiquitous beta(1A) but not the muscle-specific splice variant, beta(1D), or leukocyte-specific beta(7) cytoplasmic domains. The ability of CD98 to associate with integrin cytoplasmic domains correlated with its capacity to reverse suppression of integrin activation. The association of CD98 with integrin beta(1A) cytoplasmic domains may regulate the function and localization of these membrane proteins.


Subject(s)
Antigens, CD/metabolism , Carrier Proteins/metabolism , Cytoplasm/metabolism , Integrins/metabolism , RNA Splicing , Amino Acid Sequence , Antigens, CD/genetics , Carrier Proteins/genetics , Cell Line , Contractile Proteins/metabolism , Filamins , Fusion Regulatory Protein-1 , Integrins/chemistry , Microfilament Proteins/metabolism , Molecular Sequence Data , Protein Binding , Sequence Homology, Amino Acid , Talin/metabolism
3.
J Biol Chem ; 273(51): 33897-900, 1998 Dec 18.
Article in English | MEDLINE | ID: mdl-9852038

ABSTRACT

Increased integrin ligand binding affinity (activation) is triggered by intracellular signaling events. A Ras-initiated mitogen-activated protein kinase pathway suppresses integrin activation in fibroblasts. We used expression cloning to isolate cDNAs that prevent Ras suppression of integrin activation. Here, we report that PEA-15, a small death effector domain (DED)-containing protein, blocks Ras suppression. PEA-15 does not block the capacity of Ras to activate the ERK mitogen-activated protein kinase pathway. Instead, it inhibits suppression via a pathway blocked by a dominant-negative form of the distinct small GTPase, R-Ras. Heretofore, all known DEDs functioned in the regulation of apoptosis. In contrast, the DED of PEA-15 is essential for its capacity to reverse suppression of integrin activation. Thus, certain DED-containing proteins can regulate integrin activation as opposed to apoptotic protease cascades.


Subject(s)
Integrins/physiology , Phosphoproteins/physiology , ras Proteins/metabolism , Amino Acid Sequence , Animals , Apoptosis , CHO Cells , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cloning, Molecular , Cricetinae , Integrins/chemistry , Integrins/genetics , Mitogen-Activated Protein Kinase 1 , Molecular Sequence Data , Phosphoproteins/chemistry , Phosphoproteins/genetics , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/metabolism , Sequence Alignment , Sequence Homology, Amino Acid , Transfection
4.
Nature ; 390(6655): 81-5, 1997 Nov 06.
Article in English | MEDLINE | ID: mdl-9363894

ABSTRACT

The integrin family of adhesion receptors are involved in cell growth, migration and tumour metastasis. Integrins are heterodimeric proteins composed of an alpha and a beta subunit, each with a large extracellular, a single transmembrane, and a short cytoplasmic domain. The dynamic regulation of integrin affinity for ligands in response to cellular signals is central to integrin function. This process is energy dependent and is mediated through integrin cytoplasmic domains. However, the cellular machinery regulating integrin affinity remains poorly understood. Here we describe a genetic strategy to disentangle integrin signalling pathways. Dominant suppression occurs when overexpression of isolated integrin beta1 cytoplasmic domains blocks integrin activation. Proteins involved in integrin signalling were identified by their capacity to complement dominant suppression in an expression cloning scheme. CD98, an early T-cell activation antigen that associates with functional integrins, was found to regulate integrin activation. Furthermore, antibody-mediated crosslinking of CD98 stimulated beta1 integrin-dependent cell adhesion. These data indicate that CD98 is involved in regulating integrin affinity, and validate an unbiased genetic approach to analysing integrin signalling pathways.


Subject(s)
Antigens, CD/physiology , Carrier Proteins/physiology , Integrins/physiology , Animals , Antibodies, Monoclonal , Binding Sites , CHO Cells , Cell Adhesion , Cloning, Molecular , Cricetinae , Fusion Regulatory Protein-1 , Genetic Complementation Test , Humans , Integrin alpha6beta1 , Integrins/genetics , Molecular Sequence Data , Platelet Glycoprotein GPIIb-IIIa Complex/genetics , Platelet Glycoprotein GPIIb-IIIa Complex/physiology , Recombinant Fusion Proteins/genetics , Signal Transduction , Suppression, Genetic , Tumor Cells, Cultured
5.
Mol Plant Microbe Interact ; 8(5): 666-73, 1995.
Article in English | MEDLINE | ID: mdl-7579612

ABSTRACT

Tobacco mosaic virus (TMV) which contains the movement protein (MP) of odontoglossum ringspot tobamovirus (ORSV) in place of the TMV MP systemically infects orchids but causes local infection in tobacco unless the carboxy-terminal 48 amino acids of the MP are deleted (C. A. Holt, C. A. Fenczik, S. J. Casper, and R. N. Beachy; Virology, in press, 1995). Frameshift mutations were created within the 3' ends of the MP gene that led to truncations of the ORSV MP by 11, 19, 28, 37, and 48 amino acids; each of the mutant MP genes was inserted into the cloned cDNA of TMV in place of the TMV MP and infectious transcripts were produced. Virus containing mutant MPs were used to infect vanilla orchids, a systemic host of ORSV, and tobacco plants. Removal of 11 amino acids from the ORSV MP prevented spread of the chimeric virus in orchids while restoring the ability to cause a systemic infection on tobacco. Further deletions of the MP affected the size of virus-induced necrotic local lesions on tobacco cv. Xanthi NN and the systemic spread and accumulation of virus in cv. Xanthi nn, a systemic host of TMV. However, each virus replicated to equivalent levels in protoplasts. A mechanism by which the ORSV MP limits the spread of the chimeric virus is proposed.


Subject(s)
Mutagenesis , Tobamovirus/genetics , Viral Proteins/genetics , Amino Acid Sequence , Base Sequence , Cell Line , DNA, Complementary , Frameshift Mutation , Molecular Sequence Data , Plant Viral Movement Proteins , Plants, Genetically Modified , Plants, Toxic , Protein Biosynthesis , Protoplasts/metabolism , Sequence Deletion , Nicotiana/virology , Tobamovirus/pathogenicity , Viral Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...